Browsed by
Month: January 2022

Joget Raises $2.2 Million Pre-Series A Funding

Joget Raises $2.2 Million Pre-Series A Funding

COLUMBIA, Md., Jan. 12, 2022 /PRNewswire/ — Joget, Inc., a global open source no-code/low-code application development platform company for faster and simpler digital transformation, announced today that it has closed a $2.2 million pre-Series A funding round from private investors.

Incorporated in 2014, Joget’s next generation no-code/low-code application platform Joget DX allows business users and professional developers to collaborate and accelerate building enterprise applications with a visual drag-and-drop approach. According to Gartner’s research, 41% of employees outside of IT – or business technologists – customize or build data or technology solutions. By the end of 2025, Gartner predicts that half of all new low-code clients will come from business buyers outside the IT organization. ...  Read more

Social Capital Builders, Edward DeJesus, Makes Social Capital Literacy His Mission During National Mentoring Month

Social Capital Builders, Edward DeJesus, Makes Social Capital Literacy His Mission During National Mentoring Month

LAUREL, MD, UNITED STATES, January 11, 2022 /EINPresswire.com/ — Edward DeJesus knows the power of social capital. As a young father in his teens growing up in the Bronx, N.Y., he had to make the decision to go to college or get a full-time rotating shift, fast food job. The problem – he would not be able to attend college because of the shift work the job required. When telling a good friend about his predicament, he was advised, “Stop, I know someone who can help. You have another move.” Thanks to his best friend, and the social capital assets that DeJesus didn’t know he had, he was able to dodge the fast-food job and get a full-time evening job working with unemployed homeless men in New York City. ...  Read more

Gain Therapeutics Announces R&D Day Event and Participation in Upcoming Conferences

Gain Therapeutics Announces R&D Day Event and Participation in Upcoming Conferences

BETHESDA, Md., Jan. 18, 2022 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”), a biotechnology company focused on identifying and optimizing allosteric binding sites that have never been targeted in neurodegenerative diseases and lysosomal storage disorders, today announced that it will be hosting an R&D Day Event and participating in upcoming scientific conferences. Please see additional details below: ...  Read more

Institute for Bioscience and Biotechnology Research Receives $16.8 M Investment from the National Institute of Standards and Technology

Institute for Bioscience and Biotechnology Research Receives $16.8 M Investment from the National Institute of Standards and Technology

New Cooperative Agreement to Aid in the Development of Therapeutics and Vaccines, Improve Access to Medication

ROCKVILLE, Md., Jan. 13, 2022 /PRNewswire/ — The Institute for Bioscience and Biotechnology Research (IBBR) announces a newly funded five-year cooperative agreement with the National Institute of Standards and Technology (NIST) headed by the Co-Directors of IBBR, Dr. David J. Weber (PI) and Dr. John Marino (NIST). This award provides more than $3.3 million each year to support groundbreaking research, including technology and standards development that will impact vaccine and therapeutic discovery and development, and to improve access to life-saving treatments for addressing other crucial health challenges. ...  Read more